Outset medical Inc
Outset Medical (OM) designs and manufactures haemodialysis systems intended for hospital, clinic and home settings. The company is best known for the Tablo system, which targets simplification of dialysis delivery and operational efficiency. As a small-cap medical-device business (market capitalisation provided at around $271m), Outset sits in a competitive, highly regulated healthcare segment where growth depends on clinical adoption, reimbursement policies and hospital procurement cycles. Potential upside comes from rising demand for dialysis services globally and any gains in market share for easier-to-use or lower-cost systems. Key risks include regulatory review, reimbursement pressures, execution on manufacturing and commercial scale-up, and the typical volatility of smaller, growth-oriented healthcare firms. This profile is educational and not investment advice — investors should review the company’s latest regulatory filings, recent results and consult a financial professional to assess suitability given that share values can fall as well as rise.
Stock Performance Snapshot
Analyst Rating
Analysts encourage buying Outset Medical's stock with a target price of $5.4, indicating growth potential.
Financial Health
Outset Medical is generating moderate revenue and cash flow, but its profit margins are relatively low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring OM
At-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: August 30, 2025
Explore BasketWearable Tech IP Wars: What Investors Should Know
Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.
Published: August 21, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Adoption Opportunity
The Tablo system aims to simplify dialysis delivery, which could support commercial adoption — though uptake depends on clinical acceptance and procurement cycles.
Global Demand Trends
Ageing populations and rising chronic kidney disease suggest structural demand for dialysis, yet reimbursement and regional regulation can strongly influence outcomes.
Execution Risks
Scaling manufacturing, navigating approvals and competing with larger players are key execution challenges; small-cap stocks can be particularly volatile.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
